Blog & News
Follow along for updates and insights on how we’re helping to drive the future of healthcare innovation.
Practical Applications of FDA’s Guidelines on Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
On August 31, 2023, the U.S. Food and Drug Administration (FDA) released “Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products: Guidance for Industry.”[1] FDA issued this guidance...
Practical Applications of FDA’s Guidelines on Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
On August 31, 2023, the U.S. Food and Drug Administration (FDA) released “Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products: Guidance for Industry.”[1] FDA issued this guidance...
Practical Applications of FDA’s Guidelines on Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
On August 31, 2023, the U.S. Food and Drug Administration (FDA) released “Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products: Guidance for Industry.”[1] FDA issued this guidance...
OMNY Health and Datavant Announce Alliance to Accelerate Delivery of Real-World Data Between Healthcare Stakeholders to Enhance Clinical Research and Drug Development
– Collaboration enables provider organizations to deliver de-identified, longitudinal data sets to life science companies and other trial sponsors – – Real-world data offers unique insights in clinical research as drug developers focus on increasing equity in...
OMNY Health Presenting and Exhibiting at ISPOR Annual
Visit the Booth OMNY Health will be presenting and exhibiting at ISPOR Annual on May 7-10, 2023 in Boston, Massachusetts at Booth #1325. Schedule an in-person meeting to learn more about: Clinical measures and social determinants of health data extracted from clinical...
Top Of Mind in Q1 2023
We are nearing the close of Q1 and our provider ecosystem partners have been actively sharing information with us on their key pain points and strategic priorities for this year. Here are the issues they reported as “top of mind” in our latest strategic discussions:...
Atropos Health Expands Evidence Network by Teaming with OMNY Health
Collaboration enables Atropos to generate real-world evidence from OMNY's vast portfolio of data, opening the door for more data-driven medical breakthroughs PALO ALTO, Calif., March 8, 2023 – Atropos Health, a leader in generating personalized real-world...
Register to View Wet Age-Related Macular Degeneration: Trends in Real-World Treatment Patterns in the United States
On November 6 - November 9, 2022, this poster was on display at ISPOR Europe 2022 What is the Objective of this Poster? The objective of this study was to characterize real-world treatment patterns among wet AMD patients in diverse healthcare delivery settings in the...